How many studies have been conducted on Epimedium Brevicornum?

BiohacksAI has indexed 138 PubMed studies on Epimedium Brevicornum, including 3 randomized controlled trials (RCTs). 9% of studies involve human subjects.

What are the main research areas for Epimedium Brevicornum?

The primary research domains for Epimedium Brevicornum are 🔬 Oncology, 🔬 Inflammation, 🧠 Neuroprotection. This is based on analysis of 138 PubMed studies using the BiohacksAI evidence platform.

Epimedium Brevicornum

138+ PubMed studies analyzed · 3 RCTs · Evidence Score: 32.1

Research Domains

Epimedium Brevicornum has been studied across 24 research domains including 🔬 Oncology, 🔬 Inflammation, 🧠 Neuroprotection, 🧘 Stress & Anxiety, 🧬 Hormones. The primary research focus is 🔬 Oncology with 23% of studies addressing this area.

Traditional Use (Ayurveda)

Known as yinyanghuo / 淫羊藿 in Ayurveda.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Epimedium Brevicornum, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Loading evidence profile...

This evidence profile for Epimedium Brevicornum is generated deterministically from 138 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.